This study compared new therapeutic drugs approved by both Health Canada and the Food and Drug Administration (FDA) between 2000 and 2014 to evaluate concordance on priority review status
This study compared new therapeutic drugs approved by bothHealth Canada and the Food and Drug Administration (FDA) between 2000 and 2014 to evaluateconcordance on priority review status